Revvity launches its first set of IVD Mimix reference standards, providing diagnostic labs with trusted quality controls for optimizing tests and monitoring workflows
The new 10-year contract will focus on strengthening the partnership for continued transformative innovation for patients
The blood test market worldwide is today around $75-80 billion
With robust FY26 growth, plans AI-led diagnostics and genomic testing expansion
The newly classified assays join Roche’s Ionify 25-Hydroxy Vitamin D total assay in a growing U.S. portfolio
Under the agreement, healthcare professionals in the country will gain access to C2N’s PrecivityAD2 blood test
The facility is dedicated to breakthrough innovations in laboratory instruments that detect infectious diseases, cancer, and blood disorders
The state-of-the-art laboratory opens at the Corewell Health Southfield Center in early 2027
This move positions the U.S.-based consumer healthcare company for a significantly larger role in the rapidly expanding at-home and retail diagnostic testing market
Subscribe To Our Newsletter & Stay Updated
